The spectrum of African Kaposi's sarcoma: Is it consequential upon diverse immunological responses?

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 3, 1996, Pages 225-230

  Matondo, Patrick ^a,c   Zumla, Allimuddin ^b  

^a UNIVERSITY OF ZAMBIA   (Zambia)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICA; CELLULAR IMMUNITY; CHILD; CLINICAL FEATURE; DISEASE COURSE; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; KAPOSI SARCOMA; MALE; MULTIPLE CANCER; SEX DIFFERENCE; SHORT SURVEY;

EID: 0029738942     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609027161     Document Type: Short Survey

References (51)

1. Armes J. A review of Kaposi's Sarcoma. Adv Cancer Res 53: 73-87, 1989 .
2. Penn I. Kaposi's Sarcoma in organ transplant recipients. Transplantation 27: 8-11, 1979.
3. Shell AGR. Cancer in organ transplant recipients: part of an induced immune deficiency syndrome. BMJ 288: 659-661, 1984.
4. Gange RW, Wilson-Jones E. Kaposi's Sarcoma and immunosuppressive therapy: an appraisal. Clin Exp Dermatol 3: 135-145, 1978.
5. Taylor JF, Templeton AC, Vogel CL, Ziegler JL. Kyalwazi SK. Kaposi's Sarcoma in Uganda: a clinico-pathological study. Int J Cancer 8: 122-135, 1971.
6. Bayley AC. Aggressive Kaposi's Sarcoma in Zambia, 1983. Lancet 1: 1318-1320, 1984.
7. Bayley AC, Cheinsong-Popov R, Dalgleish AG. HTLV-III serology distinguishes atypical and endemic Kaposi's Sarcoma in Africa. Lancet 1: 359-361, 1985.
8. Bayley AC. Occurrence, clinical behaviour and management of Kaposi's Sarcoma in Zambia. Cancer Surv 10: 53-71, 1991.
9. Bayley AC. Atypical Kaposi's Sarcoma in Africa. In: Gotlieb GJ & Ackerman AB, eds. Kaposi's Sarcoma: a text and atlas. Philadelphia: Lea & Febiger, 151-170, 1988.
10. Matondo P. Clinical classification of African Kaposi's Sarcoma: time for reappraissal. Int J Dermatol 34: 166-167, 1995.
11. Desmond-Hellman SD, Mbinde EK, Kizito A, Hellman N, Ziegler JL. The value of a clinical definition for epidemic KS in predicting HIV seropositivity in Africa. J Acquir Immune Defic Syndr 4: 647-651, 1991.
12. Matondo P. Kaposi's Sarcoma epidemiology. Lancet 339: 93, 1992.
13. Chow JW, Lucas SB. Endemic and atypical Kaposi's sarcoma in Africa-histopathological aspects. Clin Exp Dermatol 14: 253-259, 1990.
14. Bhana D, Templeton AC, Master SP, Kyalwazi SK. Kaposi's Sarcoma of lymph nodes. Br J Cancer 24: 464-470, 1970.
15. Costa J, Rabson AS. Generalised Kaposi's Sarcoma is not a neoplasm. Lancet 1: 58, 1983.
16. Brooks JJ. Kaposi's Sarcoma: a reversible hyperplasia. Lancet 2: 1309-1311, 1986.
17. Kaaya EE, Parravicini C, Sundelin B, et al. Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma. Eur J Cancer 28A: 1890-1894, 1992.
18. Lunardi-Iskandar Y, Bryant JL, Zeman RA, Lam VH, Samaniego F, Besnier JM, Hermans P, Thierry AR, Gill P, Gallo RC. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375: 63-68, 1995.
19. Reynolds WA, Winkelmann RK, Soule EH. Kaposi's Sarcoma: a clinico-pathologic study with particular reference to its relationship to the reticulo-endethelial system. Medicine 1965; 44: 419-443.
20. Hutt MSR. The epidemiology of Kaposi's Sarcoma. Antibiotics Chemother 29: 3-8, 1981, Karger, Basel.
21. Friedman-Kien AE, Saltzman BR. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's Sarcoma. J Am Acad Dermatol 22: 237-250, 1990.
22. Matondo P, Sivapalan S. Sexually transmissible agent and African Kaposi's Sarcoma. Int J STD AIDS 7: 4-6, 1996.
23. Zeigler JL. Endemic Kaposi's sarcoma in Africa and local volcanic soil. Lancet 342: 1348-1351, 1993.
24. Montesu MA, De Marco R, Cottoni F. Soil silicates and Kaposi's Sarcoma in Sardinia. Lancet 346: 1436-1437, 1995.
25. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's Sarcoma among patients with AIDS: a sexually transmitted infection? Lancet 335: 123-128, 1990.
26. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi's Sarcoma. Science 266: 1865-1869, 1994.
27. Hyang YQ, Li JJ, Kaplan MH, et al. Human herpes-like nucleic acid in various forms of Kaposi's Sarcoma. Lancet 345: 759-761, 1995.
28. Dupin N, Grandadam M, Calvez V, et al. Herpes-like DNA sequences inpatients with Mediterranean Kaposi's Sarcoma. Lancet 345: 761-762, 1995.
29. Boshoff C, Whittby D, Hatziioannou T, Fisher C, van der Walt J, Hatzakis A, Weiss R, Schultz T. Kaposi's sarcoma associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 345: 1043-1044, 1995.
30. Giraldo G, Beth E, Couer P, Vogel CL, Dhru DS. Kaposi's Sarcoma: new model in the search for viruses associated with human malignancies. J Natl Cancer Inst 49: 1495-1507, 1972.
31. Giraldo G, Beth E, Kourlisky FM, Henle W, Henle G, Mike V, Huraux JM, Andersen HK, Gharbi MR, Kyalwazi SK, Puissant A. Antibody patterns to herpes virus in Kaposi's sarcoma: serological association of European Kaposi's sarcoma with cytomegalovirus. Int J Cancer 15: 839-848, 1975.
32. Moore P, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, Parry JP, Conley LJ, Jaffe HW, Chang Y. Kaposi's sarcoma-associated herpes virus infection prior to onset of Kaposi's sarcoma. AIDS 10: 175-80, 1996.
33. Auerbach R, Sidky YA. Nature of the stimulus leading tolymphocyte-induced angiogenesis. J Immunol 123: 751-754, 1979.
34. Levy JA, Ziegler JL. Acquired Immunodeficiency Syndrome is an opportunistic infection and Kaposi's Sarcoma results from secondary immune stimulation. Lancet 2: 78-80, 1983.
35. Naidu YM, Rosen EM, Zitnick R, Goldberg I, Mark M, Naujokas M, Polverni PJ, Nickoloff F. Role of scatter factor in the pathogenesis of AIDS-related Kaposi's sarcoma. Proc Natl Acad Sci 91: 5281-5285, 1994.
36. Taylor JF, Templeton AC, Kyalwazi SK, Lubenga A. Kaposi's Sarcoma in pregnancy: two case reports. Br J Surg 58: 577-579, 1971.
37. Templeton AC. Studies in Kaposi's Sarcoma. Postmortem findings and disease patterns in women. Cancer 30: 855-867, 1972.
38. Ziegler JL, Katongole-Mbidde E, Wabinga H, Dollman CM. Absence of sex-hormone receptors in Kaposi's Sarcoma. Lancet 345: 925, 1995.
39. Qunibi WY, Barri Y, Alfurayh O, et al. Kaposi's Sarcoma in renal transplant recipients: a report on 26 cases from a single institution. Transpl Proc 25: 1402-1405, 1993.
40. Master SP, Taylor JF, Kyalwazi SK, Ziegler JL. Immunological studies in Kaposi's Sarcoma in Uganda. Br Med J 1: 600-602, 1971.
41. Taylor JF, Ziegler JL. Delayed cutaneous hypersensitivity reactions in patients with Kaposi's Sarcoma. Br J Cancer 30: 312-318, 1974.
42. Kestens L, Meibya M, Biggar RJ, et al. Endemic African Kaposi's Sarcoma is not associated with immunodeficiency. Int J Cancer 36: 49-54, 1985.
43. Taylor JF, Iversen OH, Bjerknes R. Growth kinetics of Kaposi's Sarcoma. Br J Cancer 35: 470-478, 1977.
44. Nakamura S, Salahuddin SZ, Biberfield P, et al. Kaposi's Sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4 + cells. Science 242: 426-430, 1988.
45. Nair BC, De Vico AL, Nakamura S, et al. Identification of a major growth factor AIDS-Kaposi's Sarcoma cells as oncostatin M. Science 255: 1430-1432, 1992.
46. Miles SA, Martinez-Maza O, Rezai A, Copeland TD, Chen Y, Patel A, O'Neil T, Oroszlan S, Gallo RC, Samgadharan HG. Oncostatin M as apotent mitogen for AIDS-Kaposi's Sarcoma-derived cells. Science 255: 1432-1434, 1992.
47. Barillari G, Bounaguro L, Fiorelli V, Hoffman J, Michaels F, Gallo RC, Ensoli B. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 149: 3727-3734, 1992.
48. Ensoli B, Barillari G, Gallo RC. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol Rev 127: 147-155, 1992.
49. Modlin RL. Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 102: 828-831, 1994.
50. Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 16: 187-191, 1995.
51. Clerici M, Berzofsky JA. Cellular immunity and cytokines in HIV infection. AIDS 8(Suppl. 1): S175-S182, 1994.